Cancer & chemotherapy . 2007Kitagawa D,Saji S.The differences of standard therapy for breast cancer between Europe/America and Japanchemotherapy,operation,and radirtherapy[J].Gan To Kagaku Ryoho,2007,34(5):690-693.Kitagawa D;Saji S.The differences of standard therapy for breast cancer between ...
M.Clemons,R.Ghirif,Howell.The value of dose intensification of standard chemotherapy for advanced breast cancer using colony-stimulating factors alone,cancer treatment reviews.Cancer Treatment Reviews. 1998M.Clemons,R.Ghirif,Howell.The value of dose intensification of standard chemotherapy for advanced ...
Heather Moore, BCOP, CPP, PharmD, discusses the importance of treatment for early breast cancer, highlighting the use of chemotherapy followed by endocrine therapy. She notes that CDK4/6 inhibitors are being added for higher-risk patients, and oral selective estrogen receptor degraders may also ...
abook are like teachers 书是象老师 [translate] aAre you a returning customer 是您一名回来的顾客 [translate] aThe addition of bevacizumab to standard chemotherapy in breast cancer: which patient benefits the most? 到在乳腺癌中的标准化疗的 bevacizumab 的增加:哪个病人最得益? [translate] ...
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial. Br J Cancer 110:1139-1147.Alba E, Albanell J, de la Haba J, et al. Trastuzumab or ... Alba,E,Albanell,... - 《Cancer Research》 被引量: 9发表: 2011年 ...
The addition of trastuzumab (T) and lapatinib (L) to neoadjuvant chemotherapy increases the pathological complete response (pCR) rate in patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer. We investigated the efficacy of T or L with neoadjuvant chemotherapy an...
High incidence of Antiemetic treatment failure to standard chemotherapy in women with breast cancer – A prospective QOL study in clinical practice setting in Spain – EME-Q StudyPublication » High incidence of Antiemetic treatment failure to standard chemotherapy in women with breast cancer – A ...
I would also think that not needing axillary lymph node dissection would allow women to preserve the veins in both of their arms, which may reduce the need for central line catheter or implanted port insertion for chemotherapy. If you’ve been in practice for a long time, you probably ...
I think that increasingly for our patients with early stage triple negative breast cancer, we treat with neoadjuvant chemotherapy. I think that this is for a number of reasons, so that we could see how patients are responding to the treatments that we’re giving. But importantly, if patients...
My mother fought breast cancer for over a decade using the standard treatments of chemotherapy, surgery and radiation. After treatment, the cancer would go into remission for a few years and then reoccur in another part of her body requiring the same procedure - chemotherapy, surgery and radiatio...